Interleukin-1b (IL1) is involved in sleep regulation and sleep responses induced by influenza virus. The IL1 receptor accessory protein (AcP) and an alternatively spliced isoform of AcP found primarily in neurons, AcPb, form part of the IL1 signaling complex. IL1-induced sleep responses depend on injection time. In rat cortex, both IL1 mRNA and AcPb mRNA peak at Zeitgeber Time (ZT) 0 then decline over the daylight hours. Sleep deprivation enhances cortical IL1 mRNA and AcPb mRNA levels, but not AcP mRNA. We used wild type (WT) and AcPb knockout (KO) mice and performed sleep deprivation between ZT10 and 20 or between ZT22 and 8 based on the time of day expression profiles of AcPb and IL1. We hypothesized that the magnitude of the responses to sleep loss would be strain-and time of day-dependent. In WT mice, NREMS and REMS rebounds occurred regardless of when they were deprived of sleep. In contrast, when AcPbKO mice were sleep deprived from ZT10 to 20 NREMS and REMS rebounds were absent. The AcPbKO mice expressed sleep rebound if sleep loss occurred from ZT22 to 8 although the NREMS responses were not as robust as those that occurred in WT mice. We also challenged mice with intranasal H1N1 influenza virus. WT mice exhibited the expected enhanced sleep responses. In contrast, the AcPbKO mice had less sleep after influenza challenge compared to their own baseline values and compared to WT mice. Body temperature and locomotor activity responses after viral challenge were lower and mortality was higher in AcPbKO than in WT mice. We conclude that neuron-specific AcPb plays a critical role in host defenses and sleep homeostasis.
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Introduction
Interleukin-1b (IL1) is part of the molecular sleep homeostat in health and disease (Krueger, 2008; Imeri and Opp, 2009 ). Injection of exogenous IL1 enhances non-rapid eye movement sleep (NREMS) in multiple species. At low somnogenic doses IL1 has little effect on rapid eye movement sleep (REMS) or body temperature. Higher doses can inhibit both NREMS and REMS and induce fever (Opp et al., 1991) . Inhibition of IL1 using anti-IL1 antibodies, or a soluble IL1 receptor, or the IL1 receptor antagonist reduces the time spent in NREMS (reviewed Krueger, 2008) . Further, mice lacking the type I IL1 receptor have less spontaneous NREMS and REMS during the night hours. These mice also lack the ability to generate sleep responses to exogenous IL1 (Fang et al., 1998) . Brain levels of IL1 mRNA vary with the time of day with highest levels occurring at Zeitgeber Time (ZT) 0, the beginning of the sleep period (Taishi et al., 1997 (Taishi et al., , 2012 . Inhibiting caspase-1, the enzyme cleaves the pro-form of IL1 to produce mature IL1, reduces spontaneous NREMS and attenuates sleep responses to lipopolysaccharide (LPS; Imeri et al., 2006) . Lastly, after sleep loss and infectious challenge, sleep and brain levels of IL1 mRNA or IL1 protein are enhanced (Taishi et al., 1998; Leyva-Grado et al., 2009; reviewed Imeri and Opp, 2009) .
The IL1 receptor accessory protein (IL1R AcP) binds to the IL1/IL1 receptor complex triggering a biochemical signaling cascade. An alternatively-spliced isoform of the IL1R AcP, the neuron-specific IL1R AcP, called AcPb, is expressed predominately in brain (Smith et al., 2009; Huang et al., 2011; Taishi et al., 2012) . Previously we showed that in response to sleep loss, AcPb mRNA, but not AcP mRNA, is up-regulated in brain (Taishi et al., 
